Insider Trading & Ownership - Cherington Charles

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cherington Charles
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-10-29
Purchase
2024-11-05
12:42 pm
Eterna Therapeutics Inc.ERNACherington Charles
10% Owner
13,252,112$0$029,823,881
(Direct)
View
2023-09-11
Purchase
2023-09-11
8:24 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
2,053,789$0.5112$1,049,89712,502,868
(Indirect
Direct)
View
2023-07-31
Purchase
2023-08-25
7:33 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
880,195$0.5113$450,0447,515,093
(Indirect
Direct)
View
2023-01-04
Purchase
2023-01-06
4:45 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
743,243$1.23$914,1895,177,653
(Indirect
Direct)
View
2022-12-02
Purchase
2022-12-06
9:02 pm
Eterna Therapeutics Inc.ERNACherington Charles
Director
10% Owner
261,756$3.28$858,5601,079,977
(Direct)
View
2022-10-20
Purchase
2022-10-24
4:03 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
15,007$1.5779$23,6802,204,681
(Indirect
Direct)
View
2022-10-14
Purchase
2022-10-18
4:04 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
19,519$1.648$32,1672,189,674
(Indirect
Direct)
View
2022-10-13
Purchase
2022-10-14
4:03 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
10,481$1.6589$17,3872,170,155
(Indirect
Direct)
View
2022-09-29
Purchase
2022-09-30
4:04 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
17,900$1.8702$33,4772,159,674
(Indirect
Direct)
View
2022-09-27
Purchase
2022-09-29
4:02 pm
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
12,000$1.6851$20,2212,141,774
(Indirect
Direct)
View
2021-06-16
Sale
2021-06-21
6:00 pm
Brooklyn ImmunoTherapeutics Inc.BTXCherington Charles
Director
10% Owner
400,000$15.74$6,296,5685,894,101
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-29
Conversion
2024-11-05
12:42 pm
N/A
N/A
Eterna Therapeutics Inc.ERNACherington Charles
10% Owner
2,819,546$0.529,823,881
(Direct)
View
2024-10-29
Conversion
2024-11-05
12:42 pm
N/A
2025-09-24
Eterna Therapeutics Inc.ERNACherington Charles
10% Owner
1,368,626$029,823,881
(Direct)
View
2023-12-14
Expired
2023-12-20
10:05 am
2023-07-14
2028-07-14
Eterna Therapeutics Inc.ERNACherington Charles
10% Owner
2,831,204$08,957,180
(Direct)
View

Ownership
2022-09-14
8:04 pm
N/A
N/A
Comera Life Sciences Holdings Inc.CMRACherington Charles
10% Owner
0$02,129,774
(Direct)
View
2022-08-01
Option Award
2022-08-03
8:01 pm
N/A
2032-08-01
Brooklyn ImmunoTherapeutics Inc.BTXCherington Charles
Director
380,900$0380,900
(Direct)
View
2021-12-08
Option Award
2021-12-10
9:00 pm
N/A
2031-12-07
Brooklyn ImmunoTherapeutics Inc.BTXCherington Charles
Director
67,000$05,961,285
(Direct)
View
2021-06-01
Other
2021-12-10
9:00 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXCherington Charles
Director
92$05,961,285
(Direct)
View

Ownership
2021-04-19
7:34 pm
N/A
N/A
Brooklyn ImmunoTherapeutics Inc.BTXCherington Charles
Director
10% Owner
0$06,313,297
(Direct)
View